长链非编码RNA LINC01133调控肺腺癌细胞顺铂敏感性的作用及机制研究OA
The role and mechanism of long non-coding RNA LINC01133 in regulating cisplatin sensitivity in lung adenocarcinoma cells
目的 探讨LINC01133对肺腺癌细胞顺铂敏感性的调控作用及其潜在分子机制.方法 选取肺腺癌野生型细胞株A549及其顺铂耐药株A549/DDP作为研究对象,通过慢病毒转染技术分别构建LINC01133稳定过表达的A549细胞株及LINC01133稳定敲低的A549/DDP细胞株,并同步设置空载病毒阴性对照组.采用CCK-8法检测细胞顺铂耐药性及增殖活性,细胞划痕实验评估迁移能力,平板克隆实验检测克隆形成能力,Transwell小室法评估侵袭能力,流式细胞术分析细胞周期分布.同时,利用透射电子显微镜观察细胞超微结构,并联合Western blot-ting、酶联免疫吸附实验及乳酸脱氢酶(LDH)释放实验,从蛋白表达水平、炎症因子释放及细胞膜完整性三个维度综合评价细胞焦亡水平.结果 与对照组比较,LINC01133过表达可显著增强A549细胞对顺铂的耐药性,促进其增殖、迁移、克隆形成及侵袭能力,并抑制细胞S期进程.在焦亡相关指标方面,LINC01133过表达组细胞超微结构保持完整,焦亡相关蛋白Cleaved Caspase-1及GSDMD-N表达水平下调,细胞上清液中炎症因子IL-1β、IL-18浓度及LDH释放率均显著降低.反之,在A549/DDP细胞中敲低LINC01133表达后,细胞顺铂耐药性及上述恶性表型均被显著抑制,同时伴随细胞焦亡程度加剧,各相关指标均呈现相反方向的显著变化.上述差异均具有统计学意义(P<0.001或P<0.000 1).结论 LINC01133可通过抑制Caspase-1/GSDMD信号通路介导细胞焦亡,从而增强肺腺癌细胞的顺铂耐药性及恶性生物学表型,提示LINC01133可能是逆转顺铂耐药的潜在干预靶点.
Objective To investigate the regulatory role of LINC01133 in cisplatin sensitivity of lung adenocarcinoma cells and its underlying molecular mechanisms.Methods The lung adenocarcinoma wild-type cell line A549 and its cispla-tin-resistant derivative A549/DDP were selected as research subjects.Lentiviral transfection technology was used to con-struct A549 cells with stable LINC01133 overexpression and A549/DDP cells with stable LINC01133 knockdown,with empty vector negative control groups established simultaneously.The CCK-8 assay was employed to detect cisplatin resis-tance and proliferative activity.Wound healing assay was used to evaluate migration ability,colony formation assay to as-sess clonogenic capacity,Transwell assay to evaluate invasive ability,and flow cytometry to analyze cell cycle distribution.Additionally,transmission electron microscopy was performed to observe cellular ultrastructure.Western blotting,enzyme-linked immunosorbent assay(ELISA),and lactate dehydrogenase(LDH)release assay were combined to comprehensively evaluate pyroptosis levels from three dimensions:protein expression,inflammatory cytokine release,and cell membrane in-tegrity.Results Compared with controls,LINC01133 overexpression significantly enhanced cisplatin resistance in A549 cells,promoted their proliferation,migration,colony formation,and invasion capabilities,and concurrently reduced the pro-portion of cells in S phase.Regarding pyroptosis-related indicators,cells in the LINC01133 overexpression group main-tained intact ultrastructure,showed downregulated expression of pyroptosis-associated proteins Cleaved Caspase-1 and GS-DMD-N,and exhibited significantly reduced levels of inflammatory cytokines IL-1β and IL-18 as well as decreased LDH release rate in the supernatant.Conversely,LINC01133 knockdown in A549/DDP cells significantly reversed cisplatin re-sistance and the aforementioned malignant phenotypes,accompanied by enhanced pyroptosis,with all related indicators showing opposite and significant changes.All differences were statistically significant(P<0.001 or P<0.000 1).Conclusion LINC01133 enhances cisplatin resistance and malignant biological phenotypes in lung adenocarcinoma cells by inhibiting Caspase-1/GSDMD signaling pathway-mediated pyroptosis,suggesting that LINC01133 may serve as a potential interven-tion target for reversing cisplatin resistance.
徐绯翼;张璨;张有为;陈永刚
徐州医科大学 徐州临床学院,江苏 徐州,221009徐州市中心医院 肿瘤内科,江苏 徐州,221009徐州市中心医院 肿瘤内科,江苏 徐州,221009徐州医科大学 徐州临床学院,江苏 徐州,221009
医药卫生
肺腺癌LINC01133顺铂耐药细胞焦亡Caspase-1/GSDMD通路
Lung adenocarcinomaLINC01133Cisplatin resistancePyroptosisCaspase-1/GSDMD pathway
《肿瘤药学》 2026 (3)
310-319,10
国家自然科学基金面上项目(81973346)、江苏省十四五医学重点学科(ZDXK202237).
评论